Reinfection with different Omicron sub-types possible: Danish study

Reinfection with different sub-types of the Omicron variant of Covid-19 is possible, says a new study published by Denmark's Statens Serum Institut (SSI).

Omicron, Covid-19, Coronavirus
According to the study, until December 2021, the majority of those infected with Omicron in Denmark had been affected by BA.1.
IANS Copenhagen
2 min read Last Updated : Feb 23 2022 | 11:45 AM IST

Reinfection with different sub-types of the Omicron variant of Covid-19 is possible, says a new study published by Denmark's Statens Serum Institut (SSI).

However, "this seems to occur relatively rarely in Denmark, and reinfections have mainly affected younger unvaccinated individuals", Xinhua news agency quoted the SSI, Denmark's public health and research institution, as saying in the report published on Tuesday.

"None of the infected individuals became seriously ill, and none required admission to hospital."

According to the study, PCR tests carried out on approximately two million Danes affected primarily by Omicron's sub-types BA.1 and BA.2 revealed that "67 cases in which the same individual had become infected twice at a 20-60-day interval where both infections were due to Omicron sub-types".

According to the study, until December 2021, the majority of those infected with Omicron in Denmark had been affected by BA.1, which was also the most prevalent sub-type worldwide.

However, in January 2022, PCR tests revealed that BA.2 was gradually increasing in prevalence to the point where "this variant currently accounts for most coronavirus infections in Denmark, whereas BA.1 is now seen much more rarely".

The SSI recorded 30,480 new cases and 34 deaths in the past 24 hours, bringing the national totals to 2,637,414 cases and 4,375 deaths since the pandemic began.

The country also registered 124,149 cases of reinfection.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Feb 23 2022 | 11:45 AM IST

Next Story